{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T01:31:37Z","timestamp":1790299897330,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,10,25]],"date-time":"2013-10-25T00:00:00Z","timestamp":1382659200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1007\/s00415-013-7166-x","type":"journal-article","created":{"date-parts":[[2013,10,23]],"date-time":"2013-10-23T23:39:11Z","timestamp":1382571551000},"page":"98-105","source":"Crossref","is-referenced-by-count":22,"title":["Differential diagnoses to MS: experiences from an optic neuritis clinic"],"prefix":"10.1007","volume":"261","author":[{"given":"Henrik","family":"Horwitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Friis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Signe","family":"Modvig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanne","family":"Roed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Tsakiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bjarne","family":"Laursen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jette Lautrup","family":"Frederiksen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,10,25]]},"reference":[{"key":"7166_CR1","unstructured":"(2008) Multiple sclerosis risk after optic neuritis: final optic neuritis treatment trial follow-up. Arch Neurol 65:727\u2013732"},{"key":"7166_CR2","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1212\/WNL.0b013e3182190f74","volume":"76","author":"N Asgari","year":"2011","unstructured":"Asgari N, Lillevang ST, Skejoe HP, Falah M, Stenager E, Kyvik KO (2011) A population-based study of neuromyelitis optica in Caucasians. Neurology 76:1589\u20131595","journal-title":"Neurology"},{"key":"7166_CR3","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s10072-010-0222-8","volume":"31","author":"PM Bandettini di","year":"2010","unstructured":"di Bandettini PM, Primavera A, Capello E, Bandini F, Mazzarello G, Viscoli C, Schenone A (2010) A case of secondary syphilis presenting as optic neuritis. Neurol Sci 31:365\u2013367","journal-title":"Neurol Sci"},{"key":"7166_CR4","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1056\/NEJM199202273260901","volume":"326","author":"RW Beck","year":"1992","unstructured":"Beck RW, Cleary PA, Anderson MM Jr, Keltner JL, Shults WT, Kaufman DI, Buckley EG, Corbett JJ, Kupersmith MJ, Miller NR (1992) A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group. N Engl J Med 326:581\u2013588","journal-title":"N Engl J Med"},{"key":"7166_CR5","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jns.2010.05.009","volume":"295","author":"F Blanc","year":"2010","unstructured":"Blanc F, Ballonzoli L, Marcel C, De MS, Jaulhac B, De SJ (2010) Lyme optic neuritis. J Neurol Sci 295:117\u2013119","journal-title":"J Neurol Sci"},{"key":"7166_CR6","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1055\/s-2000-6838","volume":"20","author":"T Constantino","year":"2000","unstructured":"Constantino T, Digre K, Zimmerman P (2000) Neuro-ophthalmic complications of sarcoidosis. Semin Neurol 20:123\u2013137","journal-title":"Semin Neurol"},{"key":"7166_CR7","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/j.1468-1331.2011.03529.x","volume":"19","author":"M Cossburn","year":"2012","unstructured":"Cossburn M, Tackley G, Baker K, Ingram G, Burtonwood M, Malik G, Pickersgill T, te Water NJ, Robertson N (2012) The prevalence of neuromyelitis optica in South East Wales. Eur J Neurol 19:655\u2013659","journal-title":"Eur J Neurol"},{"key":"7166_CR8","first-page":"73","volume":"14","author":"ER Eggenberger","year":"2001","unstructured":"Eggenberger ER (2001) Inflammatory optic neuropathies. Ophthalmol Clin North Am 14:73\u201382","journal-title":"Ophthalmol Clin North Am"},{"key":"7166_CR9","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/ibd.20584","volume":"15","author":"T Felekis","year":"2009","unstructured":"Felekis T, Katsanos K, Kitsanou M, Trakos N, Theopistos V, Christodoulou D, Asproudis I, Tsianos EV (2009) Spectrum and frequency of ophthalmologic manifestations in patients with inflammatory bowel disease: a prospective single-center study. Inflamm Bowel Dis 15:29\u201334","journal-title":"Inflamm Bowel Dis"},{"key":"7166_CR10","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1136\/jnnp.50.6.758","volume":"50","author":"DA Francis","year":"1987","unstructured":"Francis DA, Compston DA, Batchelor JR, McDonald WI (1987) A reassessment of the risk of multiple sclerosis developing in patients with optic neuritis after extended follow-up. J Neurol Neurosurg Psychiatry 50:758\u2013765","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"7166_CR11","doi-asserted-by":"crossref","unstructured":"Frigui M, Frikha F, Sellemi D, Chouayakh F, Feki J, Bahloul Z (2011) Optic neuropathy as a presenting feature of systemic lupus erythematosus: two case reports and literature review. Lupus","DOI":"10.1177\/0961203311403344"},{"key":"7166_CR12","first-page":"122","volume":"68","author":"JJ Gan","year":"2011","unstructured":"Gan JJ, Mandell AM, Otis JA, Holmuhamedova M, Perloff MD (2011) Suspecting optic neuritis, diagnosing Bartonella cat scratch disease. Arch Neurol 68:122\u2013126","journal-title":"Arch Neurol"},{"key":"7166_CR13","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1016\/S0140-6736(02)11919-2","volume":"360","author":"SJ Hickman","year":"2002","unstructured":"Hickman SJ, Dalton CM, Miller DH, Plant GT (2002) Management of acute optic neuritis. Lancet 360:1953\u20131962","journal-title":"Lancet"},{"key":"7166_CR14","unstructured":"http: www.who.int\/classifications\/icd\/en\/GRNBOOK.pdf (2013) The ICD-10 classification of mental and behavioural disorders"},{"key":"7166_CR15","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1136\/jnnp.39.3.283","volume":"39","author":"WM Hutchinson","year":"1976","unstructured":"Hutchinson WM (1976) Acute optic neuritis and the prognosis for multiple sclerosis. J Neurol Neurosurg Psychiatry 39:283\u2013289","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"7166_CR16","doi-asserted-by":"crossref","unstructured":"Jacob A, Panicker J, Lythgoe D, Elsone L, Mutch K, Wilson M, Das K, Boggild M (2013) The epidemiology of neuromyelitis optica amongst adults in the Merseyside county of United Kingdom. J Neurol","DOI":"10.1007\/s00415-013-6926-y"},{"key":"7166_CR17","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jns.2010.07.011","volume":"298","author":"S Jarius","year":"2010","unstructured":"Jarius S, Frederikson J, Waters P, Paul F, Akman-Demir G, Marignier R, Franciotta D, Ruprecht K, Kuenz B, Rommer P, Kristoferitsch W, Wildemann B, Vincent A (2010) Frequency and prognostic impact of antibodies to aquaporin-4 in patients with optic neuritis. J Neurol Sci 298:158\u2013162","journal-title":"J Neurol Sci"},{"key":"7166_CR18","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jns.2010.01.002","volume":"291","author":"S Jarius","year":"2010","unstructured":"Jarius S, Probst C, Borowski K, Franciotta D, Wildemann B, Stoecker W, Wandinger KP (2010) Standardized method for the detection of antibodies to aquaporin-4 based on a highly sensitive immunofluorescence assay employing recombinant target antigen. J Neurol Sci 291:52\u201356","journal-title":"J Neurol Sci"},{"key":"7166_CR19","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1600-0420.2007.01034.x","volume":"86","author":"K Kallenbach","year":"2008","unstructured":"Kallenbach K, Frederiksen JL (2008) Unilateral optic neuritis as the presenting symptom of human immunodeficiency virus toxoplasmosis infection. Acta Ophthalmol 86:459\u2013460","journal-title":"Acta Ophthalmol"},{"key":"7166_CR20","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.ohc.2004.05.005","volume":"17","author":"JB Kerrison","year":"2004","unstructured":"Kerrison JB (2004) Optic neuropathies caused by toxins and adverse drug reactions. Ophthalmol Clin North Am 17:481\u2013488","journal-title":"Ophthalmol Clin North Am"},{"key":"7166_CR21","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1177\/1352458511424590","volume":"18","author":"W Kim","year":"2012","unstructured":"Kim W, Lee JE, Li XF, Kim SH, Han BG, Lee BI, Kim JK, Choi K, Kim HJ (2012) Quantitative measurement of anti-aquaporin-4 antibodies by enzyme-linked immunosorbent assay using purified recombinant human aquaporin-4. Mult Scler 18:578\u2013586","journal-title":"Mult Scler"},{"key":"7166_CR22","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","volume":"364","author":"VA Lennon","year":"2004","unstructured":"Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K, Nakashima I, Weinshenker BG (2004) A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 364:2106\u20132112","journal-title":"Lancet"},{"key":"7166_CR23","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1093\/rheumatology\/keq111","volume":"49","author":"A Massara","year":"2010","unstructured":"Massara A, Bonazza S, Castellino G, Caniatti L, Trotta F, Borrelli M, Feggi L, Govoni M (2010) Central nervous system involvement in Sjogren\u2019s syndrome: unusual, but not unremarkable\u2014clinical, serological characteristics and outcomes in a large cohort of Italian patients. Rheumatology (Oxford) 49:1540\u20131549","journal-title":"Rheumatology (Oxford)"},{"key":"7166_CR24","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jns.2007.06.038","volume":"262","author":"C Orssaud","year":"2007","unstructured":"Orssaud C, Roche O, Dufier JL (2007) Nutritional optic neuropathies. J Neurol Sci 262:158\u2013164","journal-title":"J Neurol Sci"},{"key":"7166_CR25","doi-asserted-by":"crossref","first-page":"e133","DOI":"10.1371\/journal.pmed.0040133","volume":"4","author":"F Paul","year":"2007","unstructured":"Paul F, Jarius S, Aktas O, Bluthner M, Bauer O, Appelhans H, Franciotta D, Bergamaschi R, Littleton E, Palace J, Seelig HP, Hohlfeld R, Vincent A, Zipp F (2007) Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica. PLoS Med 4:e133","journal-title":"PLoS Med"},{"key":"7166_CR26","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/WNO.0b013e31820cf78a","volume":"31","author":"V Purvin","year":"2011","unstructured":"Purvin V, Sundaram S, Kawasaki A (2011) Neuroretinitis: review of the literature and new observations. J Neuroophthalmol 31:58\u201368","journal-title":"J Neuroophthalmol"},{"key":"7166_CR27","first-page":"1668","volume":"109","author":"JF Rizzo III","year":"1991","unstructured":"Rizzo JF III, Lessell S (1991) Optic neuritis and ischemic optic neuropathy. Overlapping clinical profiles. Arch Ophthalmol 109:1668\u20131672","journal-title":"Overlapping clinical profiles. Arch Ophthalmol"},{"key":"7166_CR28","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1212\/WNL.45.2.244","volume":"45","author":"M Rodriguez","year":"1995","unstructured":"Rodriguez M, Siva A, Cross SA, O\u2019Brien PC, Kurland LT (1995) Optic neuritis: a population-based study in Olmsted County, Minnesota. Neurology 45:244\u2013250","journal-title":"Neurology"},{"key":"7166_CR29","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/01.nrl.0000254705.39956.34","volume":"13","author":"LA Rolak","year":"2007","unstructured":"Rolak LA, Fleming JO (2007) The differential diagnosis of multiple sclerosis. Neurologist 13:57\u201372","journal-title":"Neurologist"},{"key":"7166_CR30","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/00019052-200402000-00006","volume":"17","author":"JC Rucker","year":"2004","unstructured":"Rucker JC, Biousse V, Newman NJ (2004) Ischemic optic neuropathies. Curr Opin Neurol 17:27\u201335","journal-title":"Curr Opin Neurol"},{"key":"7166_CR31","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/ana.410270406","volume":"27","author":"M Sandberg-Wollheim","year":"1990","unstructured":"Sandberg-Wollheim M, Bynke H, Cronqvist S, Holtas S, Platz P, Ryder LP (1990) A long-term prospective study of optic neuritis: evaluation of risk factors. Ann Neurol 27:386\u2013393","journal-title":"Ann Neurol"},{"key":"7166_CR32","doi-asserted-by":"crossref","unstructured":"Siuko M, Tienari PJ, Saastamoinen KP, Atula S, Miettinen A, Kivela T, Setala K (2013) Neuromyelitis optica and aquaporin-4 (AQP4) autoantibodies in consecutive optic neuritis patients in Southern Finland. Acta Ophthalmol","DOI":"10.1111\/aos.12187"},{"key":"7166_CR33","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1212\/WNL.50.3.708","volume":"50","author":"M Soderstrom","year":"1998","unstructured":"Soderstrom M, Ya-Ping J, Hillert J, Link H (1998) Optic neuritis: prognosis for multiple sclerosis from MRI, CSF, and HLA findings. Neurology 50:708\u2013714","journal-title":"Neurology"},{"key":"7166_CR34","first-page":"99","volume":"15","author":"P Waters","year":"2008","unstructured":"Waters P, Vincent A (2008) Detection of anti-aquaporin-4 antibodies in neuromyelitis optica: current status of the assays. Int MS J 15:99\u2013105","journal-title":"Int MS J"},{"key":"7166_CR35","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/WNO.0b013e31815bf865","volume":"27","author":"H Wilhelm","year":"2007","unstructured":"Wilhelm H, Peters T, Ludtke H, Wilhelm B (2007) The prevalence of relative afferent pupillary defects in normal subjects. J Neuroophthalmol 27:263\u2013267","journal-title":"J Neuroophthalmol"},{"key":"7166_CR36","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1212\/WNL.53.5.1107","volume":"53","author":"DM Wingerchuk","year":"1999","unstructured":"Wingerchuk DM, Hogancamp WF, O\u2019Brien PC, Weinshenker BG (1999) The clinical course of neuromyelitis optica (Devic\u2019s syndrome). Neurology 53:1107\u20131114","journal-title":"Neurology"},{"key":"7166_CR37","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S1474-4422(07)70216-8","volume":"6","author":"DM Wingerchuk","year":"2007","unstructured":"Wingerchuk DM, Lennon VA, Lucchinetti CF, Pittock SJ, Weinshenker BG (2007) The spectrum of neuromyelitis optica. Lancet Neurol 6:805\u2013815","journal-title":"Lancet Neurol"},{"key":"7166_CR38","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","volume":"66","author":"DM Wingerchuk","year":"2006","unstructured":"Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG (2006) Revised diagnostic criteria for neuromyelitis optica. Neurology 66:1485\u20131489","journal-title":"Neurology"},{"key":"7166_CR39","unstructured":"www.medstat.dk (2012) Statens Serum Institut"},{"key":"7166_CR40","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.preteyeres.2010.11.002","volume":"30","author":"P Yu-Wai-Man","year":"2011","unstructured":"Yu-Wai-Man P, Griffiths PG, Chinnery PF (2011) Mitochondrial optic neuropathies\u2014disease mechanisms and therapeutic strategies. Prog Retin Eye Res 30:81\u2013114","journal-title":"Prog Retin Eye Res"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-013-7166-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-013-7166-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-013-7166-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,31]],"date-time":"2019-07-31T03:21:29Z","timestamp":1564543289000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-013-7166-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,25]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["7166"],"URL":"https:\/\/doi.org\/10.1007\/s00415-013-7166-x","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,25]]}}}